Show Health and Fitness Publications

Tue, October 2, 2012

[ Tue, Oct 02nd 2012 ] - Market Wire

Aeterna Zentaris Presented Poster on Oral Prostat .. 120, at International Urology Conference in Japan

[ Tue, Oct 02nd 2012 ] - Market Wire

ABRAXANE Meets Primary Endpoint of Progression-Fr .. otherapy-Naï;ve Metastatic Melanoma Study

[ Tue, Oct 02nd 2012 ] - Market Wire

RXi Pharmaceuticals to Present at 11th Annual BIO Investor Forum

[ Tue, Oct 02nd 2012 ] - Market Wire

NewLink to Present at 3rd Annual Cancer Immunotherapy Conference

[ Tue, Oct 02nd 2012 ] - Market Wire

LCA-Vision Reports Third Quarter 2012 Procedure Volume

[ Tue, Oct 02nd 2012 ] - Market Wire

Investigational New Drug Application Cleared for Omeros' Lead Compound in PDE10 Program

[ Tue, Oct 02nd 2012 ] - Market Wire

New Data Show no!no! Hair Dominates the Japanese Market for Women’s Hair Removal Devices

[ Tue, Oct 02nd 2012 ] - Market Wire

Antares Pharma Receives Development Milestone Payment

[ Tue, Oct 02nd 2012 ] - Market Wire

Spectrum Pharmaceuticals to Present Corporate Upd .. IO Investor Forum in San Francisco on October 9th

[ Tue, Oct 02nd 2012 ] - Market Wire

Biostar Pharmaceuticals, Inc. To Manufacture And .. ply Xijing Military Hospital With Three New Drugs

[ Tue, Oct 02nd 2012 ] - Market Wire

DARA BioSciences Regains Compliance with NASDAQ $1.00 Minimum Bid Price Rule

[ Tue, Oct 02nd 2012 ] - Market Wire

Studies assess linagliptin treatment in adults wi .. (T2D), as well as add-on to basal insulin therapy

[ Tue, Oct 02nd 2012 ] - Market Wire

Lilly and Boehringer Ingelheim Present Health Out .. for Investigational Novel Basal Insulin Analogue

[ Tue, Oct 02nd 2012 ] - Market Wire

OncoSec Medical to Present at 3rd Annual Cancer Immunotherapy Conference

[ Tue, Oct 02nd 2012 ] - Market Wire

Life Technologies establece un nuevo estndar mundial con el kit GlobalFilera" Express

[ Tue, Oct 02nd 2012 ] - Market Wire

Department of Justice Drops DaVita Inquiry

[ Tue, Oct 02nd 2012 ] - Market Wire

NTRR Formulates Plan to Dramatically Reduce Global Alcohol Addiction

[ Tue, Oct 02nd 2012 ] - Market Wire

Medicure Announces Intention to Seek Expanded Aggrastat Label

Mon, October 1, 2012

[ Mon, Oct 01st 2012 ] - Market Wire

Law Offices of Howard G. Smith Announces Investigation of Questcor Pharmaceuticals, Inc.

[ Mon, Oct 01st 2012 ] - Market Wire

HealthSpring Unveils 2013 Medicare Advantage Plans with More Choices

[ Mon, Oct 01st 2012 ] - Market Wire

Luminex Corporation Participates in Community Initiatives to Save Lives

[ Mon, Oct 01st 2012 ] - Market Wire

Tenet Announces Four-Point Plan to Drive Shareholder Value Creation

[ Mon, Oct 01st 2012 ] - Market Wire

Extendicare Announces Exercise of Over-Allotment .. Closes on Lease of Remaining Two Kentucky Centers

[ Mon, Oct 01st 2012 ] - Market Wire

Care Improvement Plus Unveils 2013 Medicare Advantage Plans

[ Mon, Oct 01st 2012 ] - Market Wire

XDx Appoints Peter Maag as President and CEO

[ Mon, Oct 01st 2012 ] - Market Wire

Horizon Pharma Announces Completion of Sales Force Expansion

[ Mon, Oct 01st 2012 ] - Market Wire

Implant Sciences Ships Explosives Trace Detectors .. to Protect Petroleum Infrastructure and Transport

[ Mon, Oct 01st 2012 ] - Market Wire

MethylGene Presents Clinical Data on MGCD265 at t .. Society for Medical Oncology (ESMO) 2012 Congress

[ Mon, Oct 01st 2012 ] - Market Wire

FONAR Reports Record Profits From Operations for .. me Doubles From Fiscal 2011;; Revenues Inc

[ Mon, Oct 01st 2012 ] - Market Wire

Bovie Medical to present at the 2012 SeeThruEquit .. p and Microcap Conference on Tuesday, October 2nd

[ Mon, Oct 01st 2012 ] - Market Wire

AVEO and Astellas Announce New Data Presented at .. ing the Safety and Tolerability Profile of Tivoza

[ Mon, Oct 01st 2012 ] - Market Wire

GTx Announces Sale of Fareston®;

[ Mon, Oct 01st 2012 ] - Market Wire

Syneron's elurea" Kicks Off the Break Up. Get Even! Campaign

[ Mon, Oct 01st 2012 ] - Market Wire

Sunshine Heart Announces Conditional Approval of .. E From the FDA for C-Pulse(R) Heart Assist System

[ Mon, Oct 01st 2012 ] - Market Wire

Millennium and Seattle Genetics Highlight Data fr .. imab Vedotin) Trial in Patients with Newly Diagno

[ Mon, Oct 01st 2012 ] - Market Wire

Could Stem Cells Hold the Key to Treating Traumatic Brain Injuries?

Sun, September 30, 2012

[ Sun, Sep 30th 2012 ] - Market Wire

Genomic Health anuncia la presentacin de tres estudios Oncotype DX sobre cncer de mama y colon

[ Sun, Sep 30th 2012 ] - Market Wire

Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study

[ Sun, Sep 30th 2012 ] - Market Wire

Threshold Pharmaceuticals Announces Preliminary D .. H-302 in Combination With Bevacizumab in Patients

[ Sun, Sep 30th 2012 ] - Market Wire

Interim Data for Cabozantinib 40 mg Dose Cohort i .. tant Prostate Cancer Presented at ESMO 2012 Congr

[ Sun, Sep 30th 2012 ] - Market Wire

Preliminary Phase 1 Data for Cabozantinib in Japanese Patients Presented at ESMO 2012

Sat, September 29, 2012

[ Sat, Sep 29th 2012 ] - Market Wire

New Four- and Five-Year Survival Data for YERVOY& .. tment-Naï;ve and Previously-Treated Metas

[ Sat, Sep 29th 2012 ] - Market Wire

Lilly Releases Phase II Results for Monoclonal Antibody Ramucirumab in Lung Cancer

[ Sat, Sep 29th 2012 ] - Market Wire

New Four- and Five-Year Survival Data for YERVOY& .. Treatment-Naï;;ve and Previously-Treat

[ Sat, Sep 29th 2012 ] - Market Wire

New Four- and Five-Year Survival Data for YERVOY& .. in Treatment-Naï;;;ve and Previous

[ Sat, Sep 29th 2012 ] - Market Wire

New Four- and Five-Year Survival Data for YERVOY& .. umab) in Treatment-Naï;;;;ve and

[ Sat, Sep 29th 2012 ] - Market Wire

New Four- and Five-Year Survival Data for YERVOY& .. limumab) in Treatment-Naï;;;;;

[ Sat, Sep 29th 2012 ] - Market Wire

New Four- and Five-Year Survival Data for YERVOY& .. (ipilimumab) in Treatment-Naï;;;;

[ Sat, Sep 29th 2012 ] - Market Wire

New Four- and Five-Year Survival Data for YERVOY& .. 59; (ipilimumab) in Treatment-Naï;;;

[ Sat, Sep 29th 2012 ] - Market Wire

ARIAD Presents Initial Clinical Proof-of-Concept .. Non-Small Cell Lung Cancer at ESMO 2012 Congress

[ Sat, Sep 29th 2012 ] - Market Wire

Updated Results from Phase 2b/3 GALAXY Trial Show .. vival from the Addition of Ganetespib to Docetaxe

[ Sat, Sep 29th 2012 ] - Market Wire

Exelixis Announces Data Presentation for GDC-0973 (XL518)

Fri, September 28, 2012

[ Fri, Sep 28th 2012 ] - Market Wire

Unilens Vision Reports FY2012 Operating Results

[ Fri, Sep 28th 2012 ] - Market Wire

Dehaier Medical Signed an Exclusive Distribution .. GCE Group, Europe's Leading Gas-equipment Company

[ Fri, Sep 28th 2012 ] - Market Wire

Mondo Guerra of Project Runway All Stars Hosts In .. ct at One of the Largest Annual HIV Gatherings in

[ Fri, Sep 28th 2012 ] - Market Wire

Biotech Industry Look to Benefit From the Introdu .. Technology Small Business Research Incentives Act

[ Fri, Sep 28th 2012 ] - Market Wire

Dynatronics Announces Fourth Quarter and Year-End Results

[ Fri, Sep 28th 2012 ] - Market Wire

Idera Pharmaceuticals to Present at the 3rd Annual Cancer Immunotherapy Conference

[ Fri, Sep 28th 2012 ] - Market Wire

Cytomedix Announces Poster Presentation at Britis .. thetic Plastic Surgeons Annual Scientific Meeting

[ Fri, Sep 28th 2012 ] - Market Wire

A.P. Pharma Resubmits New Drug Application for AP .. the Prevention of Chemotherapy-Induced Nausea an

[ Fri, Sep 28th 2012 ] - Market Wire

Where We Are Headed - New Outlook on Alere Inc. and PerkinElmer, Inc.

[ Fri, Sep 28th 2012 ] - Market Wire

Cytori Awarded Contract Valued up to $106 Million .. arch and Development Authority (BARDA) to Develop

[ Fri, Sep 28th 2012 ] - Market Wire

AVEO and Astellas Announce Submission of New Drug .. or the Treatment of Advanced Renal Cell Carcinoma

[ Fri, Sep 28th 2012 ] - Market Wire

Shareholder Rights Law Firm Johnson & Weaver, LLP .. uestcor Pharmaceuticals Inc. for Securities Fraud

[ Fri, Sep 28th 2012 ] - Market Wire

Swissmedic Invokes Rapid Authorization Procedures for Prochymal Review

[ Fri, Sep 28th 2012 ] - Market Wire

Oncolytics Biotech Inc. Announces the Appointment of Dr. Alan J. Tuchman as Chief Medical Officer

[ Fri, Sep 28th 2012 ] - Market Wire

call for signatures

[ Fri, Sep 28th 2012 ] - Market Wire

EYLEA (aflibercept) Injection Approved for the Tr .. of Wet Age-Related Macular Degeneration in Japan

[ Fri, Sep 28th 2012 ] - Market Wire

Boston Scientific Launches Vercisea" Deep Brain Stimulation System in Europe

[ Fri, Sep 28th 2012 ] - Market Wire

Unprecedented progression-free survival benefit w .. clinically meaningful improvements in life-limit

Thu, September 27, 2012

[ Thu, Sep 27th 2012 ] - Market Wire

30 a.m. Eastern

[ Thu, Sep 27th 2012 ] - Market Wire

Dynamic Energy Alliance to Present at Undiscovered Equities' New York Conference

[ Thu, Sep 27th 2012 ] - Market Wire

Positron To Present At The 1St International Busi .. roviders, Suppliers And Consumers In Moscow, Russ

[ Thu, Sep 27th 2012 ] - Market Wire

Holzer Holzer & Fistel, LLC Announces Investigation into Peregrine Pharmaceuticals, Inc.

[ Thu, Sep 27th 2012 ] - Market Wire

Teva Expands Central Nervous System (CNS) Develop .. n of Huntexil®; Development Program Rights

[ Thu, Sep 27th 2012 ] - Market Wire

Oral Arguments in the UCSF Appeal of United State .. Judgment in Favor of InSite Vision Are Scheduled

[ Thu, Sep 27th 2012 ] - Market Wire

BioLineRx Enters into Share Purchase Agreement with Lincoln Park Capital

[ Thu, Sep 27th 2012 ] - Market Wire

Peregrine Pharmaceuticals Announces New Location of Annual Meeting of Stockholders

[ Thu, Sep 27th 2012 ] - Market Wire

A Refreshing Outlook - Consensus Reports on UnitedHealth Group Incorporated and Health Net Inc.

[ Thu, Sep 27th 2012 ] - Market Wire

Horizon Pharma to Present at the 11th Annual BIO Investor Forum

[ Thu, Sep 27th 2012 ] - Market Wire

AspenBio Plans to Initiate Pivotal Study in Fourth Quarter

[ Thu, Sep 27th 2012 ] - Market Wire

Knome Introduces the knoSYS™100; Fi .. Plug-and-Play Human Genome Interpretation System

[ Thu, Sep 27th 2012 ] - Market Wire

BioLineRx Announces Publication of EAGLE Study Re .. Efficacy in Improving Cognitive Function in Schi

[ Thu, Sep 27th 2012 ] - Market Wire

Arnold C. Hanish Elected to Board of Directors of Omeros

[ Thu, Sep 27th 2012 ] - Market Wire

Provectus Expands Protocol for Phase 1 Liver Cancer Study

[ Thu, Sep 27th 2012 ] - Market Wire

Dr. Reddy’s Announces the Launch of Montelukast Sodium Oral Granules

[ Thu, Sep 27th 2012 ] - Market Wire

Syneron anuncia el lanzamiento global de Gentle P .. ual de la European Academy of Dermatology and Ven

Wed, September 26, 2012

[ Wed, Sep 26th 2012 ] - Market Wire

Abattis to Complete Acquisition of FFE Assets &;; Domain Names

[ Wed, Sep 26th 2012 ] - Market Wire

RepliCel's Chief Medical Officer to Present at 21 .. of Dermatology &;; Venereology Congress

[ Wed, Sep 26th 2012 ] - Market Wire

Team Kids and Edwards Lifesciences Host Prominent .. , and Philanthropists for Innovative Thinkers For

[ Wed, Sep 26th 2012 ] - Market Wire

Critical Outcome Technologies Inc. Provides Busin .. s and Scientific Update at Annual General Meeting

[ Wed, Sep 26th 2012 ] - Market Wire

Endo Health Solutions Announces Receipt of Paragraph IV Certifications for OPANA ER

[ Wed, Sep 26th 2012 ] - Market Wire

Critical Alerts For Amgen, Tyco, SanDisk, Lam Research, and Eaton Released By InvestorsObserver

[ Wed, Sep 26th 2012 ] - Market Wire

Janssen and Johnson amp;; Johnson to Prese .. r Canagliflozin in the Treatment of Patients with

[ Wed, Sep 26th 2012 ] - Market Wire

Aethlon Medical Announces the Appointment of Dr. .. adem to its Extracorporeal Science Advisory Board

[ Wed, Sep 26th 2012 ] - Market Wire

GNS Healthcare and Aetna Using quot;;Big D .. tics to Help Prevent Heart and Metabolic Diseases

[ Wed, Sep 26th 2012 ] - Market Wire

Pfizer and GlaxoSmithKline Rise After Moody's Upgrades Pharmaceutical Industry Outlook to "Stable"

[ Wed, Sep 26th 2012 ] - Market Wire

Medicure Announces Development of Novel AGGRASTAT Formulation

[ Wed, Sep 26th 2012 ] - Market Wire

Threshold Pharmaceuticals Announces Presentations .. 302 in Pancreatic Cancer and Glioblastoma at ESMO

[ Wed, Sep 26th 2012 ] - Market Wire

BIOGEN IDEC AND SOBI ANNOUNCE POSITIVE TOP-LINE R .. VESTIGATING LONG-LASTING RECOMBINANT FACTOR IX FC

[ Wed, Sep 26th 2012 ] - Market Wire

Uroplasty Announces Coverage of Percutaneous Tibi .. s Urgent PC Neuromodulation System by ConnectiCar

[ Wed, Sep 26th 2012 ] - Market Wire

Frederic Chereau Joins Shire Human Genetic Therapies to Lead Angioedema Franchise

[ Wed, Sep 26th 2012 ] - Market Wire

VentriPoint to Present at the 2012 Aegis Healthcare Conference

[ Wed, Sep 26th 2012 ] - Market Wire

Cutting-edge Robotics Allow Users to Be in 2 Places at Once

Tue, September 25, 2012

[ Tue, Sep 25th 2012 ] - Market Wire

Health Net Announces Appearance at Sanford Bernstein 3rd Annual Healthcare Reform Conference

[ Tue, Sep 25th 2012 ] - Market Wire

Leading Investment Service Examines Cosmetic and Med-Tech Stocks

[ Tue, Sep 25th 2012 ] - Market Wire

Waters Selects Metabolomics Laboratory at Univers .. rth Texas for Center of Innovation Program Honors

[ Tue, Sep 25th 2012 ] - Market Wire

Humana’s Provider Quality Rewards Progr .. illion to Primary Care Physicians Across the U.S.

[ Tue, Sep 25th 2012 ] - Market Wire

International Stem Cell Corp Granted Key Patent for Liver Disease Program

[ Tue, Sep 25th 2012 ] - Market Wire

Neogen reports record first quarter revenue and net income

[ Tue, Sep 25th 2012 ] - Market Wire

Mallinckrodt Joins The Partnership at Drugfree.org to Launch The Medicine Abuse Project

[ Tue, Sep 25th 2012 ] - Market Wire

Extendicare Completes $110 Million Offering of 6. .. nnounces Redemption of Its 7.25% Convertible Debe

[ Tue, Sep 25th 2012 ] - Market Wire

Sunshine Biopharma's Adva-27a Preclinical Researc .. Published in October Issue of ANTICANCER RESEARCH

[ Tue, Sep 25th 2012 ] - Market Wire

AspenBio to Provide Investors with Clinical and Business Update

[ Tue, Sep 25th 2012 ] - Market Wire

Aeterna Zentaris Granted Patent by European Paten .. r AEZS-130 in Growth Hormone Deficiency Diagnosis

[ Tue, Sep 25th 2012 ] - Market Wire

Life Technologies Launches Pervenioa" Lung RS, a .. k Stratification Test for Early Stage Lung Cancer

[ Tue, Sep 25th 2012 ] - Market Wire

Antares Pharma Announces Successful Results from VIBEX MTX Actual Human Use Study

[ Tue, Sep 25th 2012 ] - Market Wire

DARA BioSciences Establishes Vertically Integrate .. for Specialty Oncology Care and Support Products

[ Tue, Sep 25th 2012 ] - Market Wire

GenVec Announces Reduction in Workforce

[ Tue, Sep 25th 2012 ] - Market Wire

OncoSec Establishes Clinical Site for Its Phase I .. static Melanoma Trial at University of Washington

[ Tue, Sep 25th 2012 ] - Market Wire

China to Expand National Health Coverage to Include 20 Major Diseases

Mon, September 24, 2012

[ Mon, Sep 24th 2012 ] - Market Wire

Former Attorney General of Louisiana and Kahn Swi .. Investigate Questcor Pharmaceuticals Inc. Follow

[ Mon, Sep 24th 2012 ] - Market Wire

ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment

[ Mon, Sep 24th 2012 ] - Market Wire

pSivida Corp. Reports Fourth Quarter and Fiscal Year 2012 Results

[ Mon, Sep 24th 2012 ] - Market Wire

Boston Therapeutics Announces Filing of S-1 Registration Statement

[ Mon, Sep 24th 2012 ] - Market Wire

Boston Scientific immette in commercio in Europa .. ettrocatetere impiantabile per la defibrillazione

[ Mon, Sep 24th 2012 ] - Market Wire

Boston Scientific gibt die markteinfhrung einer n .. ibrillationselektrode in Europa und Asien bekannt

[ Mon, Sep 24th 2012 ] - Market Wire

New data from Boehringer Ingelheim and Lilly show .. ength of Diabetes Alliance at EASD Annual Meeting

[ Mon, Sep 24th 2012 ] - Market Wire

Peregrine Pharmaceuticals Announces That It Has D .. in Treatment Group Coding by an Independent Thir

[ Mon, Sep 24th 2012 ] - Market Wire

Savient Pharmaceuticals Names John P. Hamill Chief Financial Officer

[ Mon, Sep 24th 2012 ] - Market Wire

Valeant Pharmaceuticals Acquires Visudyne From QLT

[ Mon, Sep 24th 2012 ] - Market Wire

Spectrum Pharmaceuticals Provides Update on Belin .. r the Treatment of Relapsed/Refractory Peripheral

[ Mon, Sep 24th 2012 ] - Market Wire

RXi Pharmaceuticals Announces Completion of Dosing in Phase 1 Trial for RXI-109 Program

[ Mon, Sep 24th 2012 ] - Market Wire

Implant Sciences Appoints Former Rapiscan Sales Manager to Accelerate Growth in Air Cargo Market

[ Mon, Sep 24th 2012 ] - Market Wire

Medivation Effects a 2-For-1 Forward Split of Its Common Stock

[ Mon, Sep 24th 2012 ] - Market Wire

Teleflex Receives FDA 510(k) Clearance for ARROW& .. e; Continuous Peripheral Nerve Block Catheter

[ Mon, Sep 24th 2012 ] - Market Wire

BioLineRx Receives Notice of Allowance from USPTO .. n BL-1020, Extending Patent Protection Until 2031

[ Mon, Sep 24th 2012 ] - Market Wire

Sanofi Selects BioClinica’s OnPoint as Enterprise CTMS

Sun, September 23, 2012

[ Sun, Sep 23rd 2012 ] - Market Wire

Linaclotide riceve il parere positivo del CHMP per il trattamento della IBS-C

Fri, September 21, 2012

[ Fri, Sep 21st 2012 ] - Market Wire

LED Medical Diagnostics Inc. Amends Relationship with Henry Schein, Inc.

[ Fri, Sep 21st 2012 ] - Market Wire

Glancy Binkow & Goldberg LLP Announces Lead Plain .. tion Lawsuit Against Assisted Living Concepts, In

[ Fri, Sep 21st 2012 ] - Market Wire

MedCath Announces Filing of Certificate of Dissolution;; Delisting From NASDAQ

[ Fri, Sep 21st 2012 ] - Market Wire

Magellan Health Services Announces Third Quarter 2012 Earnings Conference Call

[ Fri, Sep 21st 2012 ] - Market Wire

Regeneron Announces FDA Approval of EYLEA (aflibe .. ar Edema Following Central Retinal Vein Occlusion

[ Fri, Sep 21st 2012 ] - Market Wire

Regeneron Named World's #1 Biopharmaceutical Employer in Science Magazine Annual Survey

[ Fri, Sep 21st 2012 ] - Market Wire

Pfizer Invites Public To View And Listen To Webcast Of October 30 Conference Call With Analysts

[ Fri, Sep 21st 2012 ] - Market Wire

EYLEA (aflibercept) Injection Recommended for App .. of Wet Age-Related Macular Degeneration in Europe

[ Fri, Sep 21st 2012 ] - Market Wire

CHMP Recommends Approval of Cialis for the Treatm .. igns and Symptoms of Benign Prostatic Hyperplasia

[ Fri, Sep 21st 2012 ] - Market Wire

Dehaier Medical Wins Three Year Procurement Agree .. om Major Ukrainian Medical Equipment Manufacturer

[ Fri, Sep 21st 2012 ] - Market Wire

Vanderbilt University and Bristol-Myers Squibb Si .. Develop Novel Treatments for Parkinson’

[ Fri, Sep 21st 2012 ] - Market Wire

Dynatronics Introduces New SolarisPlus Line of Therapy Products

[ Fri, Sep 21st 2012 ] - Market Wire

The Journal Science Again Recognizes Abbott as On .. loyers in the Biotech and Pharmaceutical Industry

[ Fri, Sep 21st 2012 ] - Market Wire

Amedisys Provides Seniors with Tips for September Falls Prevention Month

[ Fri, Sep 21st 2012 ] - Market Wire

ELIQUIS®; (apixaban) Receives CHMP Positiv .. Of Stroke And Systemic Embolism In Patients With

[ Fri, Sep 21st 2012 ] - Market Wire

Mylan Launches Generic Version of Antivert Tablets, 12.5 mg, 25 mg and 50 mg

[ Fri, Sep 21st 2012 ] - Market Wire

Repligen Appoints Jonathan I. Lieber as CFO

Thu, September 20, 2012

[ Thu, Sep 20th 2012 ] - Market Wire

Elan Announces the Appointment of Hans Peter Hasler as Chief Operating Officer

[ Thu, Sep 20th 2012 ] - Market Wire

Unigene To Present at the 2012 Obesity Society's 30th Annual Scientific Meeting

[ Thu, Sep 20th 2012 ] - Market Wire

AxoGen to Present at the Craig-Hallum Alpha Select Conference

[ Thu, Sep 20th 2012 ] - Market Wire

EnteroMedics to Present at Craig-Hallum 3rd Annual Alpha Select Conference

[ Thu, Sep 20th 2012 ] - Market Wire

UnitedHealthcare Volunteers at Kingsley House for AARP National Event & Expo

[ Thu, Sep 20th 2012 ] - Market Wire

Advanced Cell Technology Secures New $35 Million Funding Commitment from Lincoln Park Capital

[ Thu, Sep 20th 2012 ] - Market Wire

AspenBio to Present at 2012 Aegis Healthcare Conference

[ Thu, Sep 20th 2012 ] - Market Wire

VIVUS To Present New Data On Qsymiaa" At 30th Annual Scientific Meeting of The Obesity Society

[ Thu, Sep 20th 2012 ] - Market Wire

Acton Pharmaceuticals Announces U.S. Food and Dru .. AEROSPAN®; (Flunisolide HFA, 80 mcg) Inha

[ Thu, Sep 20th 2012 ] - Market Wire

Seattle Children's Hospital Acquires VentriPoint Heart Analysis System

[ Thu, Sep 20th 2012 ] - Market Wire

New Clinical Data on AVEO Oncology’s Ti .. tuzumab to be Presented at the ESMO 2012 Congress

[ Thu, Sep 20th 2012 ] - Market Wire

OncoSec to Present at Upcoming Healthcare and Investor Conferences

[ Thu, Sep 20th 2012 ] - Market Wire

PAREXEL and Salem State University Launch Clinical Trial Management Graduate Program

[ Thu, Sep 20th 2012 ] - Market Wire

Trovagene and Strand Life Sciences Agree to Valid .. lize Urine-Based HPV Test in India and South Asia

[ Thu, Sep 20th 2012 ] - Market Wire

United Therapeutics Announces Collaboration With .. lf-Injectable Treprostinil For Pulmonary Arterial

[ Thu, Sep 20th 2012 ] - Market Wire

Concord Medical Signs Framework Agreement to Esta .. pital in the Beijing International Medical Center

[ Thu, Sep 20th 2012 ] - Market Wire

Dr. Reddy’s Announces the Launch of Amoxicillin Tablets, Capsules, and Oral Suspension

Wed, September 19, 2012

[ Wed, Sep 19th 2012 ] - Market Wire

Matrix Medical Network Study Demonstrates Value of Year-Round Prospective Assessment Programs

[ Wed, Sep 19th 2012 ] - Market Wire

Questcor to Conduct Conference Call to Discuss Reimbursement Process

[ Wed, Sep 19th 2012 ] - Market Wire

Medicure Reports Financial Results for Fiscal 2012

[ Wed, Sep 19th 2012 ] - Market Wire

Centene Schedules 2012 Third Quarter Financial Results Conference Call

[ Wed, Sep 19th 2012 ] - Market Wire

Horizon Pharma Announces Proposed Public Offering of Common Stock

[ Wed, Sep 19th 2012 ] - Market Wire

The Law Firm of Levi &;; Korsinsky Noti .. Their Investment in Vertex Pharmaceuticals Incor

[ Wed, Sep 19th 2012 ] - Market Wire

Questcor Comments on Insurance Policy Bulletin

[ Wed, Sep 19th 2012 ] - Market Wire

Prana's PBT2 Clinical Trials Cited as Most Advanc .. generation From the Metal Equilibrium Perspective

[ Wed, Sep 19th 2012 ] - Market Wire

Lifebank and Insception Confirm Offered Consideration of $0.495 per Lifebank Common Share

[ Wed, Sep 19th 2012 ] - Market Wire

Verisante Technology, Inc. Announces Exclusive Di .. on Agreement with BO-Pharma BV for Benelux Region

[ Wed, Sep 19th 2012 ] - Market Wire

Boston Scientific to Acquire BridgePoint Medical, Inc.

[ Wed, Sep 19th 2012 ] - Market Wire

Threshold Pharmaceuticals Announces Presentation .. nancial Capital Markets' Life Sciences Exposition

[ Wed, Sep 19th 2012 ] - Market Wire

Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes

[ Wed, Sep 19th 2012 ] - Market Wire

Omeros Awarded NIMH Grant for Development of Orphan GPCR Antibodies

[ Wed, Sep 19th 2012 ] - Market Wire

Implant Sciences Hires New Sales Manager for Southeast Asia Region

[ Wed, Sep 19th 2012 ] - Market Wire

Pathogenica and Life Technologies EMEA Partner to Control Hospital Acquired Infections

[ Wed, Sep 19th 2012 ] - Market Wire

STATS ChipPAC Provides Updated Outlook for Third Quarter 2012

Tue, September 18, 2012

[ Tue, Sep 18th 2012 ] - Market Wire

Given Imaging Submits PillCam(R) COLON 2 Pivotal Trial Data to Japan's PMDA for Approval

[ Tue, Sep 18th 2012 ] - Market Wire

Pathogenica und Life Technologies EMEA schlieen P .. erschaft zur Bekmpfung von Krankenhausinfektionen

[ Tue, Sep 18th 2012 ] - Market Wire

Pathogenica y Life Technologies EMEA se unen en e .. trol de las infecciones adquiridas en el hospital

[ Tue, Sep 18th 2012 ] - Market Wire

Johnson & Johnson Launches Be Vital Challenge to .. izations Making a Difference in their Communities

[ Tue, Sep 18th 2012 ] - Market Wire

Adherex Comments on Remedial Delisting Review Initiated by the Toronto Stock Exchange

[ Tue, Sep 18th 2012 ] - Market Wire

Faruqi & Faruqi, LLP Launches Investigation Again .. tential Breaches Of Fiduciary Duties By Its Board

[ Tue, Sep 18th 2012 ] - Market Wire

MiMedx Group to Present at the BIOX;; Nobl .. nancial Capital Markets' Life Sciences Exposition

[ Tue, Sep 18th 2012 ] - Market Wire

Senesco Technologies Reports Fiscal Year 2012 Financial Results

[ Tue, Sep 18th 2012 ] - Market Wire

Gilead Sciences to Present at the UBS Global Life Sciences Conference on Wednesday, September 19

[ Tue, Sep 18th 2012 ] - Market Wire

Bristol-Myers Squibb Announces Dividend

Janssen and Johnson amp;; Johnson to Present Latest Phase 3 Results for Canagliflozin in the Treatment of Patients with

_{//health-fitness.news-articles.net/content/2012/ .. gliflozin-in-the-treatment-of-patients-with.html}
^{Published in Health and Fitness on Wednesday, September 26th 2012 at 6:45 GMT by Market Wire}

Janssen and Johnson & Johnson to Present Latest Phase 3 Results... -- NEW BRUNSWICK, N.J., Sept. 26, 2012 /PRNewswire-FirstCall/ --

Janssen and Johnson & Johnson to Present Latest Phase 3 Results for Canagliflozin in the Treatment of Patients with Type 2 Diabetes

[ ]

NEW BRUNSWICK, N.J., Sept. 26, 2012 /PRNewswire-FirstCall/ -- Janssen Research & Development, LLC and Johnson & Johnson (NYSE: [ JNJ ]) will provide a pre-recorded webcast for investors and other interested parties on Tuesday, October 2, at approximately 12:00 p.m., Eastern Time, to coincide with the 48th European Association for the Study of Diabetes (EASD) Annual Meeting in Berlin, Germany.

First results from the ongoing phase 3 CANVAS trial evaluating canagliflozin in patients with type 2 diabetes at elevated risk for cardiovascular disease will be shown at EASD. Additionally, data from DIA3010, which evaluated canagliflozin as add-on therapy in patients aged 55 to 80, on antihyperglycemic therapy without adequate glycemic control, will be presented.

A pre-recorded webcast with Kirk Ways, M.D., Ph.D, Vice President and compound development team leader for canagliflozin from Janssen Research & Development, will provide an update on the CANVAS sub-study and DIA3010 results.

The webcast/podcast can be accessed by visiting the Johnson & Johnson website at [ www.investor.jnj.com ] and clicking on "Webcasts/Presentations."

SOURCE Johnson & Johnson

[ Back to top ]

RELATED LINKS
[ http://www.jnj.com ]

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire